Angioedema Treatment Global Market Report 2026

Description

Angioedema treatment involves the medical management of swelling beneath the skin or mucous membranes, often resulting from allergic reactions, medication side effects, or genetic conditions. This swelling may be triggered by allergies, genetic factors, medications, or sometimes unknown causes, and treatment focuses on relieving symptoms, preventing airway obstruction, and reducing the frequency and severity of episodes.

The main types of angioedema treatment include allergic angioedema, drug-induced angioedema, idiopathic angioedema, and hereditary angioedema. Allergic angioedema occurs due to an allergic reaction to substances such as foods, insect bites, or medications. Treatments can be administered orally or by injection and serve a range of end-users, including hospitals, clinics, and research organizations.

Tariffs have impacted the angioedema treatment market by increasing the cost of importing biologics, C1 esterase inhibitors, and injectable therapies used in hereditary and drug-induced angioedema. Injectable and biologic segments are most affected, particularly in North America and Europe, where advanced therapies are widely used. Positively, tariffs are encouraging local production of biologics and immune therapies, improving treatment availability and reducing dependency on overseas suppliers.

The angioedema treatment market research report is one of a series of new reports from The Business Research Company that provides angioedema treatment market statistics, including angioedema treatment industry global market size, regional shares, competitors with a angioedema treatment market share, detailed angioedema treatment market segments, market trends and opportunities, and any further data you may need to thrive in the angioedema treatment industry. This angioedema treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The angioedema treatment market size has grown rapidly in recent years. It will grow from $3.13 billion in 2025 to $3.59 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to emergency allergy management, hospital-based care, corticosteroid use, antihistamine availability, limited targeted drugs.

The angioedema treatment market size is expected to see rapid growth in the next few years. It will grow to $6.18 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to biologic drug development, genetic testing growth, specialty allergy clinics, patient education, preventive care focus. Major trends in the forecast period include increased use of targeted bradykinin therapies, growth of hereditary angioedema treatments, expansion of emergency treatment protocols, improved diagnostic awareness, focus on preventive therapies.

The rising incidence of rare diseases is expected to drive the growth of the angioedema treatment market in the coming years. Rare diseases are medical conditions that affect a small portion of the population, often with limited treatment options and significant health impacts. The reported occurrence of rare diseases is increasing due to advances in genetic testing and diagnostic technologies, which enable healthcare professionals to detect and accurately diagnose conditions that were previously overlooked, resulting in higher documented prevalence. Angioedema treatments are critical for rare conditions such as hereditary angioedema, providing targeted therapies that prevent and manage severe swelling episodes, thereby improving patient outcomes. For example, in November 2024, the U.S. Food and Drug Administration (FDA) reported that over 7,000 rare diseases affect more than 30 million individuals in the United States. Therefore, the rising incidence of rare diseases is fueling growth in the angioedema treatment market.

Key companies in the angioedema treatment market are focusing on innovative solutions, such as subcutaneous injections, to provide more convenient and rapid relief for patients experiencing acute hereditary angioedema (HAE) attacks. Subcutaneous injections deliver medication into the fatty tissue beneath the skin, allowing for slow and steady absorption into the bloodstream. For instance, in April 2025, CSL Limited, an Australia-based biotechnology company, launched ANDEMBRY (garadacimab), a fully human monoclonal antibody for preventing acute HAE attacks. ANDEMBRY is the first pre-filled pen designed for once-monthly subcutaneous administration, offering a convenient long-term prophylactic option. The drug works by inhibiting activated Factor XII (Factor XIIa), a key initiator in the cascade leading to angioedema, representing a significant advancement in patient-centric HAE management.

In December 2023, Ionis Pharmaceuticals Inc., a US-based biotechnology company, partnered with Otsuka Pharmaceutical Co., Ltd., a Japan-based pharmaceutical firm, to commercialize donidalorsen in Europe for the treatment of hereditary angioedema. This collaboration aims to accelerate regulatory approval and market availability of donidalorsen in Europe, leveraging Otsuka's regional expertise to ensure access for HAE patients.

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

North America was the largest region in the angioedema treatment market in 2025. The regions covered in the angioedema treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the angioedema treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The angioedema treatment market consists of revenues earned by entities providing services, such as antihistamine administration, diagnostic services, corticosteroid therapy, genetic counseling, and immunology services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Angioedema Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses angioedema treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for angioedema treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The angioedema treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type: Allergic Angioedema; Drug-Induced Angioedema; Idiopathic Angioedema; Hereditary Angioedema
2) By Route Of Administration: Injection; Oral
3) By End Use: Hospitals; Clinics; Research Organizations
Subsegments:
1) By Allergic Angioedema: Antihistamines; Corticosteroids; Epinephrine; Immunotherapy; Allergen Avoidance Therapies
2) By Drug-Induced Angioedema: Discontinuation of Causative Drug; Antihistamines; Corticosteroids; Epinephrine; Bradykinin Pathway Inhibitors
3) By Idiopathic Angioedema: Empirical Antihistamine Therapy; Corticosteroid Therapy; Leukotriene Receptor Antagonists; Monoclonal Antibodies; Observation and Symptom Management
4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy; Bradykinin B2 Receptor Antagonists; Kallikrein Inhibitors; Attenuated Androgens; Antifibrinolytics
Companies Mentioned: Sanofi SA; Takeda Pharmaceutical Company Limited; Viatris Inc.; Otsuka Pharmaceutical Co. Ltd.; Fresenius Kabi AG; Bausch Health Companies Inc.; Apotex Inc.; Aurobindo Pharma Ltd.; Dr. Reddy's Laboratories Ltd; Cipla Inc.; Alnylam Pharmaceuticals Inc; Ionis Pharmaceuticals Inc.; Salix Pharmaceuticals Ltd; BioCryst Pharmaceuticals Inc.; Pharming Group NV; Pharvaris Netherlands B.V; Astria Therapeutics; Intellia Therapeutics; KalVista Pharmaceuticals Ltd.; ADARx Pharmaceuticals; Adverum Biotechnologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MATRE09_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Angioedema Treatment Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Angioedema Treatment Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Angioedema Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Angioedema Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Sustainability, Climate Tech & Circular Economy
4.2. Major Trends
- 4.2.1 Increased Use Of Targeted Bradykinin Therapies
- 4.2.2 Growth Of Hereditary Angioedema Treatments
- 4.2.3 Expansion Of Emergency Treatment Protocols
- 4.2.4 Improved Diagnostic Awareness
- 4.2.5 Focus On Preventive Therapies

5. Angioedema Treatment Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Clinics
5.3 Emergency Care Units
5.4 Allergy Specialty Centers
5.5 Research Organizations

6. Angioedema Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Angioedema Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Angioedema Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Angioedema Treatment Market Size, Comparisons And Growth Rate Analysis
7.3. Global Angioedema Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Angioedema Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Angioedema Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Angioedema Treatment Market Segmentation

9.1. Global Angioedema Treatment Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema
9.2. Global Angioedema Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Injection, Oral
9.3. Global Angioedema Treatment Market, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Research Organizations
9.4. Global Angioedema Treatment Market, Sub-Segmentation Of Allergic Angioedema, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies
9.5. Global Angioedema Treatment Market, Sub-Segmentation Of Drug-Induced Angioedema, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors
9.6. Global Angioedema Treatment Market, Sub-Segmentation Of Idiopathic Angioedema, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management
9.7. Global Angioedema Treatment Market, Sub-Segmentation Of Hereditary Angioedema, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

10. Angioedema Treatment Market Regional And Country Analysis

10.1. Global Angioedema Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Angioedema Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Angioedema Treatment Market

11.1. Asia-Pacific Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Angioedema Treatment Market

12.1. China Angioedema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Angioedema Treatment Market

13.1. India Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Angioedema Treatment Market

14.1. Japan Angioedema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Angioedema Treatment Market

15.1. Australia Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Angioedema Treatment Market

16.1. Indonesia Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Angioedema Treatment Market

17.1. South Korea Angioedema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Angioedema Treatment Market

18.1. Taiwan Angioedema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Angioedema Treatment Market

19.1. South East Asia Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Angioedema Treatment Market

20.1. Western Europe Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Angioedema Treatment Market

21.1. UK Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Angioedema Treatment Market

22.1. Germany Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Angioedema Treatment Market

23.1. France Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Angioedema Treatment Market

24.1. Italy Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Angioedema Treatment Market

25.1. Spain Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Angioedema Treatment Market

26.1. Eastern Europe Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Angioedema Treatment Market

27.1. Russia Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Angioedema Treatment Market

28.1. North America Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Angioedema Treatment Market

29.1. USA Angioedema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Angioedema Treatment Market

30.1. Canada Angioedema Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Angioedema Treatment Market

31.1. South America Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Angioedema Treatment Market

32.1. Brazil Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Angioedema Treatment Market

33.1. Middle East Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Angioedema Treatment Market

34.1. Africa Angioedema Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Angioedema Treatment Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By End Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Angioedema Treatment Market Regulatory and Investment Landscape

36. Angioedema Treatment Market Competitive Landscape And Company Profiles

36.1. Angioedema Treatment Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Angioedema Treatment Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Angioedema Treatment Market Company Profiles
- 36.3.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

37. Angioedema Treatment Market Other Major And Innovative Companies

Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals

38. Global Angioedema Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Angioedema Treatment Market

40. Angioedema Treatment Market High Potential Countries, Segments and Strategies

40.1 Angioedema Treatment Market In 2030 - Countries Offering Most New Opportunities
40.2 Angioedema Treatment Market In 2030 - Segments Offering Most New Opportunities
40.3 Angioedema Treatment Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer